# Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

> **NCT01612247** · NA · UNKNOWN · sponsor: **University of Vermont** · enrollment: 13 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Cyclophosphamide and Methotrexate and Aspirin

## Key facts

- **NCT ID:** NCT01612247
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2013-02
- **Final completion:** 2014-02
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2012-06-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612247, "Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01612247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*